Fig. 2From: Treatment with rituximab and brentuximab vedotin in a patient of common variable immune deficiency-associated classic Hodgkin lymphomaPET scan prior to and post treatment. a PET scan on initial diagnosis of CVID-associated classic Hodgkin lymphoma. b Post 4 weekly doses of rituximab. c Prior to brentuximab vidotin. d Post brentuximabBack to article page